IL-38 attenuates diabetic cardiomyopathy by regulating NLRP3-mediated pyroptosis via the STING signaling pathway
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.118375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Xiao Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Diabetic Cardiomyopathies, Interleukins. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Hebei Provincial Department of Science And Technology, Hebei Province Health Commission.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) represents a distinctive myocardial disorder marked by detrimental structural remodeling, encompassing cardiac hypertrophy, myocardial fibrosis, compromised coronary microvascular perfusion, and myocardial dysfunction. Pyroptosis, a newly recognized form of programmed cell death, correlates with inflammatory responses. Chronic inflammation serves a pivotal function in DCM, with pyroptosis substantially contributing to myocardial inflammation in this pathological state. IL-38 demonstrates anti-inflammatory properties through the inhibition of inflammatory signaling pathways in target cells. This investigation sought to examine whether IL-38 could alleviate DM-induced myocardial injury through the modulation of pyroptosis. Following the induction of type 2 diabetes in mice, IL-38 treatment (with or without NLRP3 overexpression) was administered for an additional 8 weeks. Cardiac function, histological architecture, and cardiomyocyte apoptosis underwent assessment. Levels of pyroptosis-related proteins and associated signaling pathways regulating pyroptosis were evaluated. Additionally, the influence of IL-38 on pyroptosis was examined in cultured primary cardiomyocytes. IL-38 demonstrated protective effects against myocardial damage both in vivo and in vitro. The expression levels of pyroptosis-associated proteins increased in type 2 diabetic mice, while IL-38 administration suppressed the pyroptotic process. Additionally, IL-38 reduced pyroptosis via modulation of the STING/NLRP3 signaling cascade. Nevertheless, enhanced NLRP3 expression or STING pathway stimulation counteracted the beneficial outcomes of IL-38.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China.
- Department of Cardiovascular Medicine, Hebei General Hospital, Heping West Road No. 348, Shijiazhuang 050000, China.
- Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shijiazhuang 050000, China; Hebei Key Laboratory of Laboratory Medicine, The Second Hospital of Hebei Med…
Förderung
- Hebei Provincial Department of Science And Technology
- Hebei Province Health Commission
Zitieren
APA
Wei, X., Liu, Y., An, D., Lv, Y., Zhou, H., & Guo, B. (2026). IL-38 attenuates diabetic cardiomyopathy by regulating NLRP3-mediated pyroptosis via the STING signaling pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118375
Vancouver
Wei X, Liu Y, An D, Lv Y, Zhou H, Guo B. IL-38 attenuates diabetic cardiomyopathy by regulating NLRP3-mediated pyroptosis via the STING signaling pathway. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118375
BibTeX
@article{Wei2026,
author = {Wei, Xiao and Liu, Yan and An, Donghui and Lv, Yuxuan and Zhou, Hong and Guo, Bingyan},
title = {IL-38 attenuates diabetic cardiomyopathy by regulating NLRP3-mediated pyroptosis via the STING signaling pathway},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.118375}
}
EUVIMED